COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2021 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
CGTX on Nasdaq
Shares outstanding
87,819,638
Price per share
$1.24
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
21,387,864
Total reported value
$28,878,511
% of total 13F portfolios
0%
Share change
+118,942
Value change
+$161,496
Number of holders
77
Price from insider filings
$1.24
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIOS Memory SPV I, LP 6.9% $15,027,696 6,059,555 AARON G.L. FLETCHER 19 Sep 2025

As of 31 Dec 2025, 77 institutional investors reported holding 21,387,864 shares of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX). This represents 24% of the company’s total 87,819,638 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) together control 23% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BIOS Capital Management, LP 6.8% 6,000,000 0% 9.8% $8,100,001
VANGUARD GROUP INC 3.8% 3,317,525 +24% 0% $4,478,658
DAVENPORT & Co LLC 3.3% 2,871,836 +6.8% 0.02% $3,876,979
BlackRock, Inc. 1.2% 1,014,338 +4.7% 0% $1,369,356
Chescapmanager LLC 1.1% 997,029 0% 0.22% $1,345,989
RENAISSANCE TECHNOLOGIES LLC 1.1% 969,513 +36% 0% $1,308,843
GEODE CAPITAL MANAGEMENT, LLC 1% 873,954 +23% 0% $1,180,167
JANE STREET GROUP, LLC 0.7% 614,261 -34% 0% $829,252
Hilton Capital Management, LLC 0.63% 548,950 -5.5% 0.06% $741,083
Dauntless Investment Group, LLC 0.53% 466,000 2.5% $629,100
STATE STREET CORP 0.36% 314,483 -3.2% 0% $424,552
Voss Capital, LP 0.32% 279,340 -6.9% 0.02% $377,109
Sigma Planning Corp 0.25% 216,165 +70% 0.01% $294,523
AMERICAN FINANCIAL GROUP INC 0.23% 205,000 0% 0.1% $276,750
CM Management, LLC 0.23% 200,000 0.23% $270,000
NORTHERN TRUST CORP 0.22% 194,314 +34% 0% $262,324
TOCQUEVILLE ASSET MANAGEMENT L.P. 0.22% 192,500 +18% 0% $259,875
CITADEL ADVISORS LLC 0.18% 161,201 0% $217,621
OMERS ADMINISTRATION Corp 0.18% 159,600 0% $215,460
Graham Capital Management, L.P. 0.17% 151,870 -33% 0.01% $205,025
Texas Capital Bank Wealth Management Services Inc 0.14% 123,296 0.01% $166,450
MORGAN STANLEY 0.11% 93,328 +185% 0% $125,993
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.1% 84,940 0% 0% $114,669
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.09% 79,993 0% $107,991
UBS Group AG 0.08% 74,332 +13% 0% $100,348

Institutional Holders of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 21,387,864 $28,878,511 +$161,496 $1.35 77
2025 Q3 21,268,922 $28,723,974 +$14,962,053 $1.35 68
2025 Q2 11,168,930 $3,463,844 -$159,050 $0.31 45
2025 Q1 11,627,581 $4,889,933 +$37,435 $0.42 48
2024 Q4 11,088,340 $7,775,058 +$595,627 $0.70 44
2024 Q3 4,253,980 $1,990,924 -$2,451,158 $0.47 39
2024 Q2 5,310,353 $8,815,784 -$2,998,367 $1.66 46
2024 Q1 7,090,800 $12,904,468 -$197,637 $1.82 46
2023 Q4 7,154,013 $13,234,773 +$56,992 $1.85 36
2023 Q3 7,236,396 $10,419,453 +$193,944 $1.44 34
2023 Q2 7,100,887 $12,994,058 -$80,887 $1.83 34
2023 Q1 7,140,406 $14,140,001 +$282,877 $1.98 32
2022 Q4 4,800,813 $10,080,423 +$4,062,100 $2.10 32
2022 Q3 5,091,352 $9,669,716 +$1,037,445 $1.90 29
2022 Q2 4,504,385 $9,489,895 +$5,791,733 $2.11 27
2022 Q1 1,666,005 $4,577,000 +$779,768 $2.75 25
2021 Q4 1,334,704 $8,437,000 +$8,437,000 $6.32 18